Real-World Outcomes of Repeat Ablation Strategies for Atrial Fibrillation: Insights From the Japanese Catheter Ablation Registry.
Yasuhiro Matsuda, Masaharu Masuda, Koshiro Kanaoka...
https://pubmed.ncbi.nlm.nih.gov/40995616Actively Recruiting
All Genders
ID03729232
Japanese Catheter Ablation Registry
Led by National Cerebral and Cardiovascular Center, Japan · Updated on 2023-11-13
400000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The Japanese Catheter Ablation (J-AB) Registry is a nationwide observational study conducted by the Japanese Heart Rhythm Society in collaboration with the National Cerebral and Cardiovascular Center. It aims to track and describe the progress and activity of catheter ablation treatments for cardiac arrhythmias across Japan. The study collects data to provide reliable information on treatment types and available facilities in arrhythmia units nationwide. Data are collected prospectively using an electronic system, including detailed information on antiarrhythmic medications gathered annually each September. The registry records the success rate of ablation procedures at hospital discharge and monitors complications, including major bleeding events. An event assessment committee evaluates the annual incidence and predictive factors related to outcomes. Participants contribute data on their catheter ablation treatment, with researchers recording outcomes such as arrhythmia recurrence up to one week after hospital discharge. Additional follow-up tracks deaths and treatment-related complications up to three months. The study is ongoing, with data collection supporting continuous monitoring of catheter ablation practices and patient outcomes in Japan.
CONDITIONS
Brief Title
Japanese Catheter Ablation Registry
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- Patients treated with catheter ablation in Japan
You will not qualify if you...
- Patients who refused to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - Not specified
Participants are screened for eligibility to participate in the trial.
Implementation
Duration - Up to 1 week through hospital discharge
Participants who undergo catheter ablation as part of routine healthcare are observed for outcomes related to the procedure.
1 hospitalization period including the ablation procedure
Long-term Monitoring
Duration - 3 months
Participants are monitored for treatment-related complications and outcomes after discharge.
Follow-up visits as per routine care
Trial Site Locations
Total: 1 location
1
National Cerebral and Cardiovascular Center
Suita, Osaka, Japan, 564-8565
Actively Recruiting
Loading map...
Research Team
K
Kengo Kusano, MD, PhD
M
Misa Takegami, PhD, MPH
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Efficacy and Safety of Second Sessions of Catheter Ablation for Idiopathic Premature Ventricular Contractions: From the Nationwide Japan Catheter Ablation Registry.
Kentaro Goto, Shinsuke Miyazaki, Reina Tonegawa-Kuji...
https://pubmed.ncbi.nlm.nih.gov/40861252Efficacy and safety of catheter ablation for paroxysmal atrial fibrillation: A comparison of first-line vs second-line therapy.
Jun Oikawa, Hidehira Fukaya, Koshiro Kanaoka...
https://pubmed.ncbi.nlm.nih.gov/40714332